Article
What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
7 Sept 2018
Abstract excerpt
Despite some remarkable innovations and the advent of novel molecular classifications the prognosis of patients with advanced gastric cancer (GC) remains overall poor and current clinical application of new advances is disappointing. During the last years only Trastuzumab and Ramucirumab have been approved and currently used as standard of care targeted therapies, but the systemic management of advanced disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
